{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:59:20Z","timestamp":1790258360724,"version":"4.1.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n                  <jats:sec>\n                    <jats:title>PURPOSE:<\/jats:title>\n                    <jats:p>Given the wide variation in intraocular pressure (IOP) response after posterior sub-Tenon triamcinolone acetonide (STTA) injection among different ethnicities, this study was conducted to evaluate the incidence of raised IOP following injection with posterior STTA in a sample of Iraqi patients with noninfectious uveitis and evaluate the main predictors of increased IOP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MATERIALS AND METHODS:<\/jats:title>\n                    <jats:p>This was a prospective clinical study conducted at the Ibn Al-Haitham Eye Teaching Hospital Uveitis Clinic between October 2, 2022, and April 1, 2024. The study included patients with noninfectious uveitis requiring treatment with posterior STTA injection. The included patients had a baseline IOP measurement before receiving 40 mg of triamcinolone acetonide. IOP measurements were then taken at 1 week and 1 month after the injection using a Keeler applanation tonometer. All measurements were performed by the same experienced ophthalmologist using the same device.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      A total of 60 patients with noninfectious uveitis who received posterior STTA injections were included in the study, consisting of 29 females and 31 males. The mean age in this study was 30.52, with a standard deviation (STD) 17.19. Thirty-one patients (51.7%) had significant IOP elevation over 1 month (more than 21 mmHg). Younger age was found to be significantly related to higher elevation in IOP over time (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .000). There was a significant change in the IOP over the period.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>There was a significant increase in IOP over the period from 1 week to 1 month. The change in IOP during this time was significantly related to age.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/tjo.tjo-d-24-00153","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T02:00:13Z","timestamp":1749434413000},"page":"480-485","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Intraocular pressure changes after posterior sub-Tenon injection of triamcinolone acetonide in a sample of Iraqi patients with noninfectious uveitis"],"prefix":"10.4103","volume":"16","author":[{"given":"Mohammed Suhail Najm","family":"Al-Salam","sequence":"first","affiliation":[{"name":"Department of Surgery, College of Medicine, Mustansiriyah University, Baghdad, Iraq"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zainab Nadom Hamoodi","family":"Al-Khafaji","sequence":"additional","affiliation":[{"name":"Department of Surgery, College of Medicine, Mustansiriyah University, Baghdad, Iraq"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Shakir Ali","family":"Al-Wassiti","sequence":"additional","affiliation":[{"name":"Department of Surgery, College of Medicine, University of Baghdad, Baghdad, Iraq"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luay Salim","family":"Rasheed","sequence":"additional","affiliation":[{"name":"Ghazi Al-Harriri Hospital for Surgical Specialities, Medical City Complex, Baghdad, Iraq"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Tareq","family":"Mutar","sequence":"additional","affiliation":[{"name":"Department of Surgery, College of Medicine, University of Baghdad, Baghdad, Iraq"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,6,9]]},"reference":[{"key":"R1-20260924","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/09273948.2016.1196713","article-title":"A focus on the epidemiology of uveitis","volume":"26","author":"Tsirouki","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"key":"R2-20260924","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4103\/0974-9233.84044","article-title":"Blindness in Iraq: Leading causes, target patients, and barriers to treatment","volume":"18","author":"Al-Shakarchi","year":"2011","journal-title":"Middle East Afr J Ophthalmol"},{"key":"R3-20260924","doi-asserted-by":"crossref","first-page":"291","DOI":"10.4103\/0974-9233.142263","article-title":"Pattern of uveitis at a referral center in Iraq","volume":"21","author":"Al-Shakarchi","year":"2014","journal-title":"Middle East Afr J Ophthalmol"},{"key":"R4-20260924","doi-asserted-by":"crossref","first-page":"233","DOI":"10.4103\/tjo.tjo_68_19","article-title":"Corticosteroids for diabetic macular edema","volume":"9","author":"Chawan-Saad","year":"2019","journal-title":"Taiwan J Ophthalmol"},{"key":"R5-20260924","doi-asserted-by":"crossref","first-page":"5300","DOI":"10.3390\/jcm10225300","article-title":"Treatment of macular edema in vascular retinal diseases: A 2021 update","volume":"10","author":"Grzybowski","year":"2021","journal-title":"J Clin Med"},{"key":"R6-20260924","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s40265-020-01314-y","article-title":"Uveitis therapy: The corticosteroid options","volume":"80","author":"Valdes","year":"2020","journal-title":"Drugs"},{"key":"R7-20260924","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jconrel.2019.01.018","article-title":"Controlled release of corticosteroid with biodegradable nanoparticles for treating experimental autoimmune uveitis","volume":"296","author":"Luo","year":"2019","journal-title":"J Control Release"},{"key":"R8-20260924","first-page":"25158414211070879","article-title":"Management of noninfectious scleritis","volume":"14","author":"Abdel-Aty","year":"2022","journal-title":"Ther Adv Ophthalmol"},{"key":"R9-20260924","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s40266-024-01105-0","article-title":"Management of scleritis in older adults","volume":"41","author":"Butler","year":"2024","journal-title":"Drugs Aging"},{"key":"R10-20260924","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11940-019-0579-9","article-title":"Treatment strategies for neuroretinitis: Current options and emerging therapies","volume":"21","author":"Fairbanks","year":"2019","journal-title":"Curr Treat Options Neurol"},{"key":"R11-20260924","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.tjo.2012.10.003","article-title":"Sequential posterior subtenon injection of triamcinolone acetonide with macular grid\/focal photocoagulation for clinically significant diabetic macular edema","volume":"2","author":"Liu","year":"2012","journal-title":"Taiwan J Ophthalmol"},{"key":"R12-20260924","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/ICU.0000000000000651","article-title":"Local treatment of infectious and noninfectious intermediate, posterior, and panuveitis: Current concepts and emerging therapeutics","volume":"31","author":"Thomas","year":"2020","journal-title":"Curr Opin Ophthalmol"},{"key":"R13-20260924","doi-asserted-by":"crossref","first-page":"181","DOI":"10.4103\/ijo.IJO_1963_22","article-title":"Commentary: Posterior subtenon triamcinolone \u2013 The unsung hero for managing various ocular disorders","volume":"71","author":"Tripathy","year":"2023","journal-title":"Indian J Ophthalmol"},{"key":"R14-20260924","doi-asserted-by":"crossref","first-page":"946","DOI":"10.18240\/ijo.2020.06.14","article-title":"Ocular hypertension and severe intraocular pressure elevation after posterior subtenon injection of triamcinolone acetonide for various diseases","volume":"13","author":"Yang","year":"2020","journal-title":"Int J Ophthalmol"},{"key":"R15-20260924","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/j.ophtha.2014.05.021","article-title":"Periocular corticosteroid injections in uveitis: Effects and complications","volume":"121","author":"Sen","year":"2014","journal-title":"Ophthalmology"},{"key":"R16-20260924","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s12348-011-0044-8","article-title":"Patterns of childhood-onset uveitis in a referral center in Turkey","volume":"2","author":"Ozdal","year":"2012","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"R17-20260924","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3109\/09273948.2013.767353","article-title":"Periocular triamcinolone acetonide injections for control of intraocular inflammation associated with uveitis","volume":"21","author":"Salek","year":"2013","journal-title":"Ocul Immunol Inflamm"},{"key":"R18-20260924","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ophtha.2015.08.042","article-title":"African ancestry is associated with higher intraocular pressure in Latinos","volume":"123","author":"Nannini","year":"2016","journal-title":"Ophthalmology"},{"key":"R19-20260924","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1001\/archopht.122.9.1270","article-title":"Clinical significance of central corneal thickness in the management of glaucoma","volume":"122","author":"Shih","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"R20-20260924","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s10384-009-0692-5","article-title":"Intraocular pressure elevation following triamcinolone acetonide administration as related to administration routes","volume":"53","author":"Hirano","year":"2009","journal-title":"Jpn J Ophthalmol"},{"key":"R21-20260924","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2147\/DDDT.S166092","article-title":"Update in treatment of uveitic macular edema","volume":"13","author":"Koronis","year":"2019","journal-title":"Drug Des Devel Ther"},{"key":"R22-20260924","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.3390\/jcm10184133","article-title":"Update on the management of uveitic macular edema","volume":"10","author":"Teper","year":"2021","journal-title":"J Clin Med"},{"key":"R23-20260924","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2147\/OPTH.S180580","article-title":"Macular edema associated with non-infectious uveitis: Pathophysiology, etiology, prevalence, impact and management challenges","volume":"13","author":"Massa","year":"2019","journal-title":"Clin Ophthalmol"},{"key":"R24-20260924","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.ophtha.2024.02.019","article-title":"Treatment of noninfectious uveitic macular edema with periocular and intraocular corticosteroid therapies: A report by the American Academy of Ophthalmology","volume":"131","author":"Smith","year":"2024","journal-title":"Ophthalmology"},{"key":"R25-20260924","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jfma.2016.09.014","article-title":"Bevacizumab and panretinal photocoagulation protect against ocular hypertension after posterior subtenon injection of triamcinolone acetonide for diabetic macular edema","volume":"116","author":"Hsieh","year":"2017","journal-title":"J Formos Med Assoc"},{"key":"R26-20260924","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3129\/i07-186","article-title":"Intraocular pressure elevation after intravitreal or posterior sub-tenon triamcinolone acetonide injection","volume":"43","author":"Yamamoto","year":"2008","journal-title":"Can J Ophthalmol"},{"key":"R27-20260924","doi-asserted-by":"crossref","first-page":"e0226118","DOI":"10.1371\/journal.pone.0226118","article-title":"Intraocular pressure elevation after subtenon triamcinolone acetonide injection; multicentre retrospective cohort study in Japan","volume":"14","author":"Maeda","year":"2019","journal-title":"PLoS One"},{"key":"R28-20260924","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1007\/s00417-023-06163-5","article-title":"Incidence and treatment approach of intraocular pressure elevation after various types of local steroids for retinal diseases","volume":"261","author":"Wykrota","year":"2023","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R29-20260924","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.ophtha.2006.01.043","article-title":"Ocular hypertension and secondary glaucoma in children with uveitis","volume":"113","author":"Sijssens","year":"2006","journal-title":"Ophthalmology"},{"key":"R30-20260924","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/j.ophtha.2015.06.041","article-title":"The risk of intraocular pressure elevation in pediatric noninfectious uveitis","volume":"122","author":"Kothari","year":"2015","journal-title":"Ophthalmology"},{"key":"R31-20260924","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/IJG.0000000000000379","article-title":"Raised intraocular pressure in nonjuvenile idiopathic arthritis-uveitis children: Risk factors and effect on retinal nerve fiber layer","volume":"25","author":"Md Din","year":"2016","journal-title":"J Glaucoma"},{"key":"R32-20260924","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jdiacomp.2005.06.015","article-title":"Posterior subtenon and intravitreal triamcinolone acetonide for diabetic macular edema","volume":"20","author":"Ozdek","year":"2006","journal-title":"J Diabetes Complications"},{"key":"R33-20260924","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10384-005-0306-9","article-title":"Risk factors for elevated intraocular pressure after trans-tenon retrobulbar injections of triamcinolone","volume":"50","author":"Hirooka","year":"2006","journal-title":"Jpn J Ophthalmol"},{"key":"R34-20260924","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1097\/IAE.0b013e31824fd384","article-title":"Comparison of intraocular pressure elevation after anterior versus posterior subtenon triamcinolone acetonide acetate injection: A retrospective study","volume":"32","author":"Liu","year":"2012","journal-title":"Retina"},{"key":"R35-20260924","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.ophtha.2007.02.010","article-title":"Randomized trial of peribulbar triamcinolone acetonide with and without focal photocoagulation for mild diabetic macular edema: A pilot study","volume":"114","author":"Chew","year":"2007","journal-title":"Ophthalmology"},{"key":"R36-20260924","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/IJG.0b013e31802d696f","article-title":"Frequency and risk factors for intraocular pressure elevation after posterior sub-tenon capsule triamcinolone acetonide injection","volume":"16","author":"Iwao","year":"2007","journal-title":"J Glaucoma"},{"key":"R37-20260924","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1186\/s12886-022-02625-2","article-title":"Comparison between intravitreal ranibizumab injection and posterior subtenon triamcinolone acetonide injection at time of cataract surgery for prevention of progression of diabetic macular edema","volume":"22","author":"Khalil","year":"2022","journal-title":"BMC Ophthalmol"},{"key":"R38-20260924","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2147\/OPTH.S442749","article-title":"Glucocorticoid-induced ocular hypertension and glaucoma","volume":"18","author":"Harvey","year":"2024","journal-title":"Clin Ophthalmol"},{"key":"R39-20260924","doi-asserted-by":"crossref","first-page":"e0151833","DOI":"10.1371\/journal.pone.0151833","article-title":"Increased intraocular pressure and hyperglycemic level in diabetic patients","volume":"11","author":"Hymowitz","year":"2016","journal-title":"PLoS One"}],"container-title":["Taiwan Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/tjo.TJO-D-24-00153","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:03:11Z","timestamp":1790254991000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/tjo.TJO-D-24-00153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,9]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/tjo.tjo-d-24-00153","relation":{},"ISSN":["2211-5056","2211-5072"],"issn-type":[{"value":"2211-5056","type":"print"},{"value":"2211-5072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,9]]},"assertion":[{"value":"2024-11-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-12","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}